MSH|^~\&|LAB|Dynacare|||20230906014313-0400||ORU^R01|20274284|D|2.3|||||||enCA
PID|1||2222226081^^^^JHN^~2BCZZG6QKL^^^^^~^^^^XXOEI^||ITTESTING^STG6081QA^||19900528|F|||12345 TEST ADDRESS^^BRAMPTON^ON^L6T5M3^||^|||||
ORC||^Dynacare|5010019823||CM||||20230825104704-0400||||||||^TEST^DYNA
OBR|1|^Dynacare|5010019823|535S^ANTI-SKIN^DYNA|||20230825104700-0400|||||||20230825104704-0400|^^^^|989898^TEST^DRTEST^^^^^^DYNA|||2BCZZG6QKL|AUTO|401120|20230905121145-0400|||F|^^||^TEST6^DYNA
OBX|1|TX|535S^ANTI-SKIN^DYNA|401120|POSITIVE|||A|||F|||20230905121145-0400
NTE|1|RS||RS^^DYNA^IM1A
NTE|2|RS|Indirect immunofluorescent staining for IgG antibodies|RS^^DYNA^IM1A
NTE|3|RS|against the basement membrane zone along the|RS^^DYNA^IM1A
NTE|4|RS|dermo-epidermal junction is present. Approximately 80|RS^^DYNA^IM1A
NTE|5|RS|percent of patients with bullous pemphigoid, epidermolysis|RS^^DYNA^IM1A
NTE|6|RS|bullosa acquisita, or linear bullous dermatosis and|RS^^DYNA^IM1A
NTE|7|RS|approximately 50 percent of patients with mucous membrane|RS^^DYNA^IM1A
NTE|8|RS|or cicatricial pemphigoid have positive antibodies. A|RS^^DYNA^IM1A
NTE|9|RS|positive result supports the diagnosis of pemphigoid.|RS^^DYNA^IM1A
NTE|10|RS|However, if clinically indicated, further evaluation is|RS^^DYNA^IM1A
NTE|11|RS|advised. Testing performed by indirect immunofluorescence|RS^^DYNA^IM1A
NTE|12|RS|for IgG antibodies against monkey esophagus.|RS^^DYNA^IM1A
NTE|13|RS||RS^^DYNA^DEO1
NTE|14|RS|DR. S.S. DEODHARE  M.D., F.R.C.P.(C)|RS^^DYNA^DEO1
NTE|15|RS||RS^^DYNA^IM5A
NTE|16|RS|Note: On April 04, 2021, methodology will change and|RS^^DYNA^IM5A
NTE|17|RS|titres will be reported up to 1:160.|RS^^DYNA^IM5A
NTE|18|RF|NEGATIVE|RF^^^
OBX|2|TX|SKINT1^TITRE:^DYNA|401120.001|1:10|||A|||F|||20230905121145-0400
NTE|1|RF|NEGATIVE|RF^^^
OBX|3|TX|SKINP1^PATTERN^DYNA|401120.002|Pemphigoid|||I|||F|||20230905121145-0400
OBR|2|^Dynacare|5010019823|048^CALCULUS ANALYSIS^DYNA|||20230825104700-0400|||||||20230825104704-0400|^^^^|989898^TEST^DRTEST^^^^^^DYNA|||2BCZZG6QKL|CHEM|200367|20230905121038-0400|||F|^^||^TEST6^DYNA
OBX|1|TX|048^CALCULUS ANALYSIS^DYNA|200367|See Notes|||I|||F|||20230905121038-0400
NTE|1|RS|This is a Laboratory Developed Test; refer to Dynacare.ca|RS^^DYNA^LDT2
NTE|2|RS|for details.|RS^^DYNA^LDT2
OBX|2|TX|COLOUR^COLOUR:^DYNA|200367.001|BEIGE|||I|||F|||20230905121038-0400
OBX|3|TX|SIZE^SIZE:^DYNA|200367.002|10 X 6 X 4|mm||I|||F|||20230905121038-0400
OBX|4|TX|SHAPE^SHAPE:^DYNA|200367.003|IRREGULAR|||I|||F|||20230905121038-0400
OBX|5|TX|CONSIS^CONSISTENCY:^DYNA|200367.004|HARD|||I|||F|||20230905121038-0400
OBX|6|TX|COMPOS^COMPOSITION:^DYNA|200367.005|50 % CALCIUM OXALATE DIHYDRATE|||I|||F|||20230905121038-0400
OBX|7|TX|COMPOS^COMPOSITION:^DYNA|200367.006|30 % CARBONATE APATITE|||I|||F|||20230905121038-0400
OBX|8|TX|COMPOS^COMPOSITION:^DYNA|200367.007|20 % CALCIUM OXALATE MONOHYDRATE|||I|||F|||20230905121038-0400
OBR|3|^Dynacare|5010019823|655^URINE PREGNANCY TEST^DYNA|||20230825104700-0400|||||||20230825104704-0400|^^^^|989898^TEST^DRTEST^^^^^^DYNA|||2BCZZG6QKL|URIN|523200|20230905121154-0400|||F|^^||^TEST6^DYNA
OBX|1|TX|655^URINE PREGNANCY TEST^DYNA|523200|POSITIVE|||A|||F|||20230905121154-0400
